MARK A. FINKELSTEIN - Corporate Board Profile

COLUMBIA BANKING SYSTEM, INC.

Filing Date	Source Excerpt
2015-03-19	Mr. Finkelstein, 56, has served since September 2014 as the Chief Legal and Administrative Officer at Blucora, Inc., where he oversees the company's legal, compliance and human resources departments and advises on legal and corporate strategy matters. From December 2011 through July 2014, he served as Executive Vice President—Corporate Development and General Counsel of Emeritus Corporation, an NYSE-listed healthcare company with over 30,000 employees, and as the Corporate Secretary of Emeritus from May 2012 through July 2014. Prior to joining Emeritus, Mr. Finkelstein served as a strategy advisor for private investment management firms in the United States and Europe and as the chief executive officer and a member of the board of directors of Novellus Capital Management, a specialized asset management firm. From 1986 to 2006, he practiced law with the Seattle law firm of Graham & Dunn, P.C., where he specialized in mergers and acquisitions, complex financing strategies and other corporate transactions involving financial service companies. Mr. Finkelstein received his B.A. with High Honors in Economics from The University of Michigan and his J.D. from The University of Michigan Law School. He is a member of the Audit and Corporate Responsibility Committee of the Board of Trustees for Seattle Children's Hospital. Mr. Finkelstein's legal, strategic management and financial expertise make him a valuable resource to the Board.
2016-03-16	Mr. Finkelstein, 57, has served since September 2014 as the Chief Legal and Administrative Officer at Blucora, Inc., where he oversees the company's legal, compliance and human resources departments and advises on legal and corporate strategy matters. From December 2011 through July 2014, he served as Executive Vice President – Corporate Development and General Counsel of Emeritus Corporation, an NYSE-listed healthcare company with over 30,000 employees, and as the Corporate Secretary of Emeritus from May 2012 through July 2014. Prior to joining Emeritus, Mr. Finkelstein served as a strategy advisor for private investment management firms in the United States and Europe and as the chief executive officer and a member of the board of directors of Novellus Capital Management, a specialized asset management firm. From 1986 to 2006, he practiced law with the Seattle law firm of Graham & Dunn, P.C., where he specialized in mergers and acquisitions, complex financing strategies and other corporate transactions involving financial service companies. Mr. Finkelstein received his B.A. with High Honors in Economics from The University of Michigan and his J.D. from The University of Michigan Law School. He is a member of the Audit and Corporate Responsibility Committee of the Board of Trustees for Seattle Children's Hospital. Mr. Finkelstein's legal, strategic management and financial expertise make him a valuable resource to the Board.
2017-04-13	Mr. Finkelstein, 58, has served since September 2014 as the Chief Legal and Administrative Officer at Blucora, Inc., where he oversees the company's legal and compliance functions and advises on legal and corporate strategy matters. From December 2011 through July 2014, he served as Executive Vice President – Corporate Development and General Counsel of Emeritus Corporation, an NYSE-listed healthcare company with over 30,000 employees, and as the Corporate Secretary of Emeritus from May 2012 through July 2014. Prior to joining Emeritus, Mr. Finkelstein served as a strategy advisor for private investment management firms in the United States and Europe and as the chief executive officer and a member of the board of directors of Novellus Capital Management, a specialized asset management firm. From 1986 to 2006, he practiced law with the Seattle law firm of Graham & Dunn, P.C., where he specialized in mergers and acquisitions, complex financing strategies and other corporate transactions involving financial service companies. Mr. Finkelstein received his B.A. with High Honors in Economics from The University of Michigan and his J.D. from The University of Michigan Law School. He is a member of the Audit and Corporate Responsibility Committee of the Board of Trustees for Seattle Children's Hospital. Mr. Finkelstein's legal, strategic management and financial expertise make him a valuable resource to the Board.
2018-04-13	Mr. Finkelstein, 59, has extensive legal background and experience with financial services companies. He served as the Chief Legal and Administrative Officer and Secretary at Blucora, Inc., a tech-enabled financial solutions business, from September 2014 through June of 2017, overseeing the company’s legal and compliance functions and advising on legal and corporate strategy matters. From December 2011 through July 2014, he served as Executive Vice President – Corporate Development and General Counsel of Emeritus Corporation, an NYSE-listed healthcare company with over 30,000 employees, and as the Corporate Secretary of Emeritus from May 2012 through July 2014. Before joining Emeritus, Mr. Finkelstein served as a strategy advisor for private investment management firms in the United States and Europe and as the chief executive officer and a member of the board of directors of Novellus Capital Management, a specialized asset management firm. From 1986 to 2006, he practiced law with the Seattle law firm of Graham & Dunn, P.C., where he specialized in mergers and acquisitions, complex financing strategies and other corporate transactions involving financial service companies. Mr. Finkelstein received his B.A. with High Honors in Economics from The University of Michigan and his J.D. from The University of Michigan Law School. He is a member of the Audit and Corporate Responsibility Committee of the Board of Trustees for Seattle Children’s Hospital. Mr. Finkelstein’s legal, strategic management and financial expertise make him a valuable resource to the Board.
2019-04-12	Mr. Finkelstein, 60, has extensive legal background and experience with financial services companies and public companies generally. ... Mr. Finkelstein’s legal, strategic management and financial expertise make him a valuable resource to the Board.
2020-04-17	Mr. Finkelstein is a member of the Board of Directors of Christensen, Inc., a leading solutions provider for the fuel, lubricants and propane industries. ... Committees: Compensation, Corporate Governance, M&A ... 2019 Director Compensation Table ... Mark A. Finkelstein ... $78,167 Fees Earned or Paid in Cash, $69,994 Stock Awards, Total $148,161.
2021-04-12	Mr. Finkelstein is a member of the Board of Directors of Christensen, Inc. He served as Chief Legal and Administrative Officer and Secretary of Blucora, Inc. He serves on the Personnel and Compensation Committee and the Corporate Governance and Nominating Committee. 2020 Director Compensation Table shows Mark A. Finkelstein total compensation as $130,986.
2022-03-18	Mr. Finkelstein is a member of the Board of Directors of Christensen, Inc. The Corporate Governance and Nominating Committee current members include M. Finkelstein (Chair), C. Eerkes, M. Finkelstein, T. Hulbert, T. Mack-Askew and J. Terrano. 2021 Director Compensation Table shows Mark A. Finkelstein total compensation as $137,455.
2023-04-06	Mark A. Finkelstein Director since: 2014 Age: 64 Mr. Finkelstein is a director of Christensen, Inc. He is also a member of the Audit and Compliance Committee of the Board of Trustees for Seattle Children’s Healthcare System and a member of the Board of Directors of the Northwest Chapter of the National Association of Corporate Directors (NACD). Board Committees: Compensation Committee, Nominating and Governance Committee 2022 Director Compensation Table: Total $123,447
2024-03-27	Mr. Finkelstein is a director of Christensen, Inc., a solutions provider for the fuel, lubricants and propane industries. He is also a member of the Governance, Audit and Compliance Committee of the Board of Trustees of Seattle Children’s Healthcare System and a member of the Board of Directors of the Northwest Chapter of the National Association of Corporate Directors (NACD). Mr. Finkelstein served as Chief Legal and Administrative Officer and Secretary of Blucora, Inc. from September 2014 through June of 2017. Mr. Finkelstein’s 2023 compensation was $229,729.
2025-04-03	Mark A. Finkelstein Independent Age: 66 Director Since: 2014 Committee Assignments: Compensation Committee, Enterprise Risk Management Committee, Nominating and Governance Committee